Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

A Comparison of Two Assessment Tools in Predicting Treatment Success of Cimzia in Rheumatoid Arthritis Subjects

ClinicalTrials.gov ID: NCT01255761

Public ClinicalTrials.gov record NCT01255761. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 20, 2026, 6:18 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase 4, Randomized, 52-Week Study To Evaluate Two Assessment Tools To Predict Treatment Success At 52 Weeks Based On A Treatment Decision At Week 12 In Subjects With Moderate To Severe Rheumatoid Arthritis Receiving Cimzia

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Phase 4 study to evaluate a routine patient completed assessment (RAPID3) compared to a physician completed assessment (CDAI) to predict treatment success with subjects with moderate to severe rheumatoid arthritis

Study identification

NCT ID
NCT01255761
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
UCB Pharma
Industry
Enrollment
736 participants

Conditions and interventions

Interventions

Biological

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 2010 (Type not available)
Primary completion
Oct 2012 (Actual)
Completion
Dec 2012 (Actual)
Last update posted
Jul 31, 2018

2010 – 2012

United States locations

U.S. sites
110
U.S. states
31
U.S. cities
101
Facility City State ZIP Site status
137 Birmingham Alabama — —
166 Huntsville Alabama — —
165 Peoria Arizona — —
216 Tucson Arizona — —
168 Hot Springs Arkansas — —
241 Jonesboro Arkansas — —
153 Little Rock Arkansas — —
111 Covina California — —
208 Escondido California — —
103 Fullerton California — —
155 Huntington Beach California — —
202 La Mesa California — —
203 Loma Linda California — —
233 Los Angeles California — —
105 Palm Desert California — —
229 Roseville California — —
113 Sacramento California — —
127 San Diego California — —
106 Santa Maria California — —
172 Santa Monica California — —
212 Upland California — —
231 Van Nuys California — —
158 Whittier California — —
121 Bridgeport Connecticut — —
200 Bridgeport Connecticut — —
107 Danbury Connecticut — —
195 Danbury Connecticut — —
138 Hamden Connecticut — —
218 Lewes Delaware — —
108 Aventura Florida — —
120 Dunedin Florida — —
101 Ocala Florida — —
225 Orange Park Florida — —
227 Ormond Beach Florida — —
184 Palm Harbor Florida — —
145 Sarasota Florida — —
191 Tampa Florida — —
236 Vero Beach Florida — —
144 Atlanta Georgia — —
232 Atlanta Georgia — —
157 Lawrenceville Georgia — —
217 Coeur d'Alene Idaho — —
206 Idaho Falls Idaho — —
193 Rock Island Illinois — —
207 Springfield Illinois — —
186 Elizabethtown Kentucky — —
204 Lexington Kentucky — —
230 Louisville Kentucky — —
149 Cumberland Maryland — —
237 Hagerstown Maryland — —
197 Wheaton Maryland — —
118 Mansfield Massachusetts — —
132 Worcester Massachusetts — —
140 Lansing Michigan — —
226 Petoskey Michigan — —
114 Saint Clair Shores Michigan — —
188 Bridgeton Missouri — —
109 St Louis Missouri — —
133 St Louis Missouri — —
124 Lincoln Nebraska — —
205 Reno Nevada — —
159 Lebanon New Hampshire — —
189 Nashua New Hampshire — —
143 Clifton New Jersey — —
125 Albuquerque New Mexico — —
175 Albany New York — —
139 Binghamton New York — —
116 Brooklyn New York — —
167 Brooklyn New York — —
196 Johnson City New York — —
174 New York New York — —
104 Orchard Park New York — —
135 Plainview New York — —
215 Rochester New York — —
178 Charlotte North Carolina — —
210 Durham North Carolina — —
234 Hickory North Carolina — —
102 Monroe North Carolina — —
152 Bethlehem Pennsylvania — —
112 Duncansville Pennsylvania — —
219 Erie Pennsylvania — —
128 Philadelphia Pennsylvania — —
147 Sellersville Pennsylvania — —
213 Willow Grove Pennsylvania — —
235 Wyomissing Pennsylvania — —
198 Charleston South Carolina — —
228 Columbia South Carolina — —
130 Hendersonville Tennessee — —
129 Jackson Tennessee — —
162 Amarillo Texas — —
110 Austin Texas — —
156 Austin Texas — —
192 Dallas Texas — —
185 El Paso Texas — —
122 Houston Texas — —
170 Houston Texas — —
123 Mesquite Texas — —
115 Nassau Bay Texas — —
117 San Antonio Texas — —
119 San Antonio Texas — —
161 San Antonio Texas — —
190 Victoria Texas — —
142 Waco Texas — —
136 Burlington Vermont — —
146 Arlington Virginia — —
150 Chesapeake Virginia — —
223 Kennewick Washington — —
134 Spokane Washington — —
221 Clarksburg West Virginia — —
194 Glendale Wisconsin — —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01255761, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 31, 2018 · Synced Oct 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01255761 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →